Abiopharma

🔍 Woodroffe Sean (Executive)

Company: LINCOLN NATIONAL CORP (LNC)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 11,000 shares of Common Stock at $45.28 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 119,947.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.22 to $45.34, inclusive. The reporting person undertakes to provide Lincoln National Corporation, any security holder of Lincoln National Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
• F2: Includes 758 shares acquired through dividend reinvestment since the reporting person's last report.